The trading price of Takeda Pharmaceutical Co ADR (NYSE:TAK) floating lower at last check on Tuesday, August 06, closing at $13.38, -3.18% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 43.84. In examining the 52-week price action we see that the stock hit a 52-week high of $16.39 and a 52-week low of $12.57. Over the past month, the stock has gained 1.52% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Takeda Pharmaceutical Co ADR, whose market valuation is $42.22 billion at the time of this writing. The dividend yield on the company stock is 4.57%, while its Forward Dividend ratio is 0.61. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.6 per share this quarter, however they have predicted annual earnings per share of 0.14 for current year and 0.38 for next year.
Analysts have forecast the company to bring in revenue of 7.47M for the current quarter, with the likely lows of 7.47M and highs of 7.48M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 30.61M.
On the technical side, indicators suggest TAK has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 2192.01, which symbolizes a positive outlook. A quick review shows that TAK’s price is currently -1.49% off the SMA20 and 0.59% off the SMA50. The RSI metric on the 14-day chart is currently showing 46.26, and weekly volatility stands at 2.89%. When measured over the past 30 days, the indicator reaches 1.55%. Takeda Pharmaceutical Co ADR (NYSE:TAK)’s beta value is currently sitting at 0.55, while the Average True Range indicator is currently displaying 0.29.
To see how Takeda Pharmaceutical Co ADR stock has been performing today in comparison to its peers in the industry, here are the numbers: TAK stock’s performance was -3.18% at last check in today’s session, and -12.03% in the past year. Takeda Pharmaceutical Co ADR has a P/E ratio of 43.84.
An evaluation of the daily trading volume of Takeda Pharmaceutical Co ADR (NYSE:TAK) indicates that the 3-month average is 2.01 million.
Currently, records show that 3.16 billion of the company’s shares remain outstanding. The insiders hold 0.02% of outstanding shares, whereas institutions hold 5.25%. However, since the stock’s price has seen -6.24% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
